These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2408923)

  • 1. Dihydropyridine Ca2+ agonists and channel blockers interact in the opposite manner with photogenerated unpaired electrons.
    Marinov BS; Saxon ME
    FEBS Lett; 1985 Jul; 186(2):251-4. PubMed ID: 2408923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.
    Affolter H; Coronado R
    Biophys J; 1985 Aug; 48(2):341-7. PubMed ID: 2413915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of Ca2+ and K+ currents in bag cell neurons of Aplysia californica by dihydropyridine Ca2+ antagonists.
    Nerbonne JM; Gurney AM
    J Neurosci; 1987 Mar; 7(3):882-93. PubMed ID: 2435867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
    Rogg H; Criscione L; Truog A; Meier M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S31-7. PubMed ID: 2414592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.
    Kokubun S; Reuter H
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4824-7. PubMed ID: 6205402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dihydropyridine calcium agonists and antagonists on neuronal voltage sensitive calcium channels.
    Creba JA; Karobath M
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1038-47. PubMed ID: 2418832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.
    Spedding M; Berg C
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):69-75. PubMed ID: 6083458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
    Rico I; Alonso MJ; Salaices M; Marín J
    Pharmacology; 1990; 40(6):330-42. PubMed ID: 1700444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic effects of Ca2+ channel agonist and antagonists in neuraminidase-treated left atria of rats.
    Hattori Y; Hazama S; Kanno M; Nakao Y
    Br J Pharmacol; 1986 Feb; 87(2):299-305. PubMed ID: 2420406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.
    Schramm M; Thomas G; Towart R; Franckowiak G
    Nature; 1983 Jun 9-15; 303(5917):535-7. PubMed ID: 6190088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.
    Hess P; Lansman JB; Tsien RW
    Nature; 1984 Oct 11-17; 311(5986):538-44. PubMed ID: 6207437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel activation in vascular smooth muscle by BAY K 8644.
    Su CM; Swamy VC; Triggle DJ
    Can J Physiol Pharmacol; 1984 Nov; 62(11):1401-10. PubMed ID: 6210137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human red blood cells--an ideal model system for the action of calcium agonists and antagonists.
    Stimpel M; Neyses L; Locher R; Groth H; Vetter W
    J Hypertens Suppl; 1984 Dec; 2(3):S577-80. PubMed ID: 6085891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blocking drugs. Part I: The calcium channel.
    Brill DM; Fozzard HA
    Compr Ther; 1985 Oct; 11(10):60-6. PubMed ID: 2414053
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium channel activation: a different type of drug action.
    Freedman SB; Miller RJ
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5580-3. PubMed ID: 6206501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine calcium channel activators and antagonists influence depolarization-evoked inositol phospholipid hydrolysis in brain.
    Kendall DA; Nahorski SR
    Eur J Pharmacol; 1985 Sep; 115(1):31-6. PubMed ID: 2412857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the voltage-dependent Ca2+ channel in rat heart cells by dihydropyridine derivatives.
    Renaud JF; Méaux JP; Romey G; Schmid A; Lazdunski M
    Biochem Biophys Res Commun; 1984 Nov; 125(1):405-12. PubMed ID: 6210086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.